...
首页> 外文期刊>Eurosurveillance >Letter to the editor: Is malaria re-emerging in southern Europe? Cryptic Plasmodium falciparum malaria in Malta, October 2018
【24h】

Letter to the editor: Is malaria re-emerging in southern Europe? Cryptic Plasmodium falciparum malaria in Malta, October 2018

机译:致编辑的信:疟疾是否正在南欧重新出现? 2018年10月,马耳他的隐性恶性疟原虫(italic)疟疾

获取原文
   

获取外文期刊封面封底 >>

       

摘要

To the editor: We read with great interest the rapid communication by Zammarchi et al. [ 1 ] describing a cryptic severe Plasmodium falciparum malaria infection in a Moroccan man living in Tuscany, Italy. The authors described that the case was unlikely to be travel-associated or a malaria relapse. Moreover, they ruled out other possible risk factors, such as transfusion, transplant or nosocomial exposure. Thus, the authors reported the occurrence of a sporadic autochthonous P. falciparum infection in Italy, almost 50 years after the elimination of malaria in southern Europe in the 1970s. In light of this unexpected case, we wish to report a cryptic case of P. falciparum diagnosed in October 2018 in Malta. A previously healthy man in his early thirties was admitted to Mater Dei Hospital in mid-October 2018 with an 8-day history of high fever, headache, vomiting, loss of appetite and dark urine. Blood tests showed anaemia (13.0g/dL; norm: 14.1–17.2g/dL), thrombocytopenia (101×10 ~(9)/L; norm: 146–302×10 ~(9)/L), low eosinophils (0.00×10 ~(9)/L; norm: 0.10–0.70×10 ~(9)/L), low lymphocyte count (0.92×10 ~(9)/L; norm: 1.30–3.60×10 ~(9)/L) and increased serum CRP (100.7mg/L norm; 0–5mg/L). Examination of blood smears showed the presence of P. falciparum in peripheral blood and PCR results confirmed P. falciparum infection with high viraemia. The patient was treated with three doses of atovaquone/proguanil (1g/400mg per day) and was discharged 4 days after hospital admission. The patient made a full recovery within 7 days. The epidemiological investigation revealed that the patient, a resident of central Malta, was born in Burkina Faso and has been living in Malta for over 10 years. The patient reported having had malaria in 2007, when they were still living in their home country. Later that year, the patient arrived as a migrant to Malta. They had not travel abroad since then. The patient works discontinuously, mainly outdoors, and reported being unemployed prior to symptom onset. The patient has no history of surgery, blood transfusion or invasive examination, denied being an injecting drug user and was not aware of having had contact with persons with similar symptoms. The patient’s residence is located ca 7 km from Malta International Airport. They noticed multiple mosquito bites during the weeks preceding illness. Extensive investigations failed to identify the potential source of this sporadic case and there was no evidence of further local transmission. During 2018, another four cases of malaria were reported in Malta (three P. falciparum and one P. vivax ). All of them were imported cases associated with recent travel to Asia or Africa. No cases of locally acquired malaria have been reported in Malta since the early 1940s, and Anopheles spp. have not been detected since its eradication in 1943 [ 2 ]. The most recent entomological investigations conducted in 2010 and 2013, involving both larval collection and adult trapping, reconfirmed the presence of Culex pipiens and demonstrated that Aedes albopictus has been introduced and established in the Maltese Islands [ 3 ]. However, no Anopheles spp. were identified in these investigations. Although unlikely, a plausible explanation may be that the patient had asymptomatic P. falciparum infection that persisted for over a decade. Recently, a case identified 13 years after initial exposure to P. falciparum malaria was reported [ 4 ]. Even though Malta is a small country, the high number of visiting tourists, along with increased numbers of migrants and favourable Mediterranean climate, increase the risk of sporadic autochthonous cases and establishment of malaria in the region. There exists an urgent need, both in Malta and in other European countries, for increased awareness of imported malaria as well as potential autochthonous malaria cases; further efforts should be made to heighten awareness among clinicians to ensure prompt detection, notification and treatment of cases, as well as timely implementation of public health control measures. The unexpected finding of this cryptic P. falciparum malaria case in Malta suggests that competent vectors for transmission may be present. This event, together with the recent P. falciparum malaria case in Italy, indicates that re-establishment of malaria in southern Europe may be possible and reinforces the need for improved surveillance and urgent vector-control actions.
机译:致编辑:我们非常感兴趣地阅读了Zammarchi等人的快速交流。 [1]描述了居住在意大利托斯卡纳的一名摩洛哥男子的一种隐秘的严重恶性疟原虫疟疾感染。作者描述,该病例不太可能与旅行相关或疟疾复发。此外,他们排除了其他可能的危险因素,例如输血,移植或医院暴露。因此,作者报告了在1970年代南欧消除疟疾近50年后,意大利发生了零星的自发性恶性疟原虫感染。鉴于这一意外情况,我们希望报告2018年10月在马耳他诊断出的一例恶性疟原虫。一名30岁早期健康的男子于2018年10月中旬入读Mater Dei医院,有8天的高烧,头痛,呕吐,食欲不振和尿黑的病史。血液测试显示贫血(13.0g / dL;正常值:14.1-17.2g / dL),血小板减少症(101×10〜(9)/ L;正常值:146–302×10〜(9)/ L),嗜酸性粒细胞低( 0.00×10〜(9)/ L;范数:0.10–0.70×10〜(9)/ L),低淋巴细胞计数(0.92×10〜(9)/ L;范数:1.30–3.60×10〜(9) / L)和血清CRP升高(正常水平为100.7mg / L; 0-5mg / L)。血液涂片检查显示外周血中存在恶性疟原虫,PCR结果证实恶性疟原虫感染高病毒血症。该患者接受了三剂阿托伐醌/异丙酚(每天1g / 400mg)治疗,入院后4天出院。病人在7天内完全康复。流行病学调查显示,该患者是马耳他中部居民,出生于布基纳法索,已经在马耳他生活了10多年。该患者报告说,他们在家乡时曾于2007年患疟疾。那年晚些时候,患者作为移民来到马耳他。从那以后,他们再也没有出国旅行。该患者不连续工作,主要是在户外工作,并报告在症状发作之前失业。该患者没有手术,输血或侵入性检查史,被否认是注射吸毒者,并且不知道曾与具有类似症状的人接触过。患者的住所距离马耳他国际机场约7公里。他们在生病前的几周内发现了多次蚊子叮咬。广泛的调查未能确定这种零星病例的潜在来源,也没有证据表明进一步的本地传播。 2018年期间,马耳他又报告了4例疟疾病例(3例恶性疟原虫和1例间日疟原虫)。所有这些都是与最近前往亚洲或非洲旅行有关的进口病例。自1940年代初以来,在马耳他和按蚊属(Anopheles spp)中均未报告本地获得性疟疾的病例。自1943年根除以来尚未发现[2]。在2010年和2013年进行的最新昆虫学调查涉及幼体收集和成年诱捕,再次证实了淡色库蚊的存在,并证明白纹伊蚊已在马耳他群岛引进和建立[3]。但是,没有按蚊属。在这些调查中被发现。尽管可能性不大,但可能的解释可能是患者无症状的恶性疟原虫感染持续了十多年。最近,报道了在首次接触恶性疟原虫疟疾13年后发现的病例[4]。尽管马耳他是一个小国,但大量游客,大量移民和有利的地中海气候,增加了该地区零星本地病例和疟疾的风险。马耳他和其他欧洲国家都迫切需要提高对进口疟疾以及潜在的自发性疟疾病例的认识;应进一步努力提高临床医生的意识,以确保及时发现,通报和治疗病例,并及时实施公共卫生控制措施。在马耳他这个神秘的恶性疟原虫疟疾病例的意外发现表明,可能存在传播的有效载体。该事件,再加上意大利最近发生的恶性疟原虫疟疾病例,表明在南欧重新建立疟疾是可能的,并加强了对监测和紧急媒介控制行动的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号